Frequent mutation of the E2F-4 cell cycle gene in primary human gastrointestinal tumors.

The E2F group of transcription factors transactivates genes that promote progression through the G1-S transition of the cell cycle. Members of the retinoblastoma (Rb) family of proteins bind to E2Fs and inhibit this function. E2F-4, one example of the E2F group, functions as an oncogene when transfected into nontransformed cells in vitro. On the other hand, mice that are homozygously lacking a normal E2F-1 gene develop cancers, consistent with a tumor-suppressive role for this gene. The exact function of E2Fs has thus been unclear; moreover, direct involvement of this gene in primary human tumorigenesis has not been shown. We, therefore, investigated mutation within the E2F-4 coding region in 16 primary gastric adenocarcinomas, 12 ulcerative colitis-associated neoplasms, 46 sporadic colorectal carcinomas, 9 endometrial cancers, and 3 prostatic carcinomas. We limited our investigation to the serine repeat within E2F-4, reasoning that this tract might be altered in genetically unstable tumors (replication error-positive, or RER+). All tumors were RER+, with the exception of a control group of 15 RER- sporadic colorectal carcinomas. PCR with incorporation of [32P]dCTP was performed using primers flanking the serine trinucleotide (AGC) repeat. Twenty-two of 59 gastrointestinal tumors (37%) contained E2F-4 mutations; these comprised 5 of 16 gastric tumors (31%), 4 of 12 ulcerative colitis-associated neoplasms (33%, including 1 dysplastic lesion), and 13 of 31 sporadic colorectal cancers (42%). No mutation was present in any of the endometrial, prostate, or RER- colorectal tumors. Of note, homozygous mutations occurred in three cases, and two of seven informative patients showed loss of one E2F-4 allele in their tumors. Furthermore, the RER+ sporadic colorectal tumors were evaluated at trinucleotide repeats within the genes for N-cadherin and B-catenin; no tumors demonstrated mutation of these genes. These data suggest that E2F-4 is a target of defective DNA repair in these tumors.

[1]  吉鷹 知也 Mutation of E'2F-4 Trinucleotide Repeats in Colorectal Cancer with Microsatellite Instability , 1997 .

[2]  G. Chenevix-Trench,et al.  Apparent protection from instability of repeat sequences in cancer-related genes in replication error positive gastrointestinal cancers , 1997, Oncogene.

[3]  N. Matsubara,et al.  Mutations of E2F-4 trinucleotide repeats in colorectal cancer with microsatellite instability. , 1996, Biochemical and biophysical research communications.

[4]  Hiroyuki Yamamoto,et al.  Frameshift mutator mutations , 1996, Nature.

[5]  T. Jacks,et al.  Tumor Induction and Tissue Atrophy in Mice Lacking E2F-1 , 1996, Cell.

[6]  M. Greenberg,et al.  E2F-1 Functions in Mice to Promote Apoptosis and Suppress Proliferation , 1996, Cell.

[7]  R. Weinberg E2F and Cell Proliferation: A World Turned Upside Down , 1996, Cell.

[8]  D. Livingston,et al.  Cyclin A-kinase regulation of E2F-1 DNA binding function underlies suppression of an S phase checkpoint , 1995, Cell.

[9]  Kathleen R. Cho,et al.  A transforming growth factor beta receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability. , 1995, Cancer research.

[10]  K. Kinzler,et al.  Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. , 1995, Science.

[11]  R. Weinberg,et al.  The retinoblastoma protein and cell cycle control , 1995, Cell.

[12]  W. Kaelin,et al.  Transcriptional control by E2F. , 1995, Seminars in cancer biology.

[13]  D. Livingston,et al.  Functional interaction between E2F-4 and p130: evidence for distinct mechanisms underlying growth suppression by different retinoblastoma protein family members. , 1995, Genes & development.

[14]  J. Nevins,et al.  E2F1 overexpression in quiescent fibroblasts leads to induction of cellular DNA synthesis and apoptosis , 1995, Journal of virology.

[15]  R. Weinberg,et al.  E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[16]  W. Lee,et al.  Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis , 1994, Molecular and cellular biology.

[17]  J. Lawrence,et al.  E2F-4, a new member of the E2F transcription factor family, interacts with p107. , 1994, Genes & development.

[18]  W. Kaelin,et al.  Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[19]  N. York,et al.  Advances in Brief Microsatellite Instability in Ulcerative Colitis-associated Colorectal Dysplasias and Cancers ' , 2006 .

[20]  E. Hudson,et al.  Advances in Brief Microsatellite Instability Occurs Frequently and in Both Diploid and Aneuploid Cell Populations of Barrett ' s-associated Esophageal Adenocarcinomas ' , 2006 .

[21]  K. Alitalo,et al.  Repression of cyclin D1: a novel function of MYC. , 1994, Molecular and cellular biology.

[22]  A. Levine,et al.  p53 and E2F-1 cooperate to mediate apoptosis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[23]  M. Beato,et al.  Inducible regulatory elements in the human cyclin D1 promoter. , 1994, Oncogene.

[24]  M. Vidal,et al.  The retinoblastoma protein binds to a family of E2F transcription factors , 1993, Molecular and cellular biology.

[25]  Darryl Shibata,et al.  Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis , 1993, Nature.

[26]  S N Thibodeau,et al.  Microsatellite instability in cancer of the proximal colon. , 1993, Science.

[27]  J. Weber,et al.  Genetic mapping of a locus predisposing to human colorectal cancer. , 1993, Science.

[28]  D. Perry Trinucleotide repeat polymorphism in the human antithrombin III (AT3) gene. , 1993, Human molecular genetics.

[29]  G. Gyapay,et al.  A second-generation linkage map of the human genome , 1992, Nature.

[30]  A. Bradley,et al.  Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis , 1992, Nature.

[31]  Marc Vidal,et al.  A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F , 1992, Cell.

[32]  L. Peltonen,et al.  An Alu variable polyA repeat polymorphism upstream of L-myc at 1p32. , 1992, Human molecular genetics.

[33]  L. Donehower,et al.  Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours , 1992, Nature.

[34]  J. Murray,et al.  A tetranucleotide repeat for the F13B locus. , 1992, Nucleic acids research.

[35]  Patricia L. Blount,et al.  Frequent loss of heterozygosity at the retinoblastoma locus in human esophageal cancers. , 1991, Cancer research.

[36]  H. Nasheuer,et al.  Human DNA polymerase alpha gene: sequences controlling expression in cycling and serum-stimulated cells , 1991, Molecular and cellular biology.

[37]  L. Strong,et al.  Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. , 1990, Science.

[38]  M Lipp,et al.  E1A-dependent trans-activation of the human MYC promoter is mediated by the E2F factor. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[39]  M Lipp,et al.  Nuclear factor E2F mediates basic transcription and trans-activation by E1a of the human MYC promoter. , 1989, Genes & development.

[40]  A. Knudson Mutation and cancer: statistical study of retinoblastoma. , 1971, Proceedings of the National Academy of Sciences of the United States of America.

[41]  B. Leggett,et al.  Microsatellite instability in the insulin–like growth factor II receptor gene in gastrointestinal tumours , 1996, Nature Genetics.

[42]  W. Park,et al.  Microsatellite instability occurs frequently in human gastric carcinoma. , 1994, Oncogene.

[43]  A. Levine,et al.  p 53 and E 2 F-1 cooperate to mediate apoptosis , 2022 .